Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic or Autologous HSCT”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Testing effectiveness (Phase 2)Study completedNCT00427765
What this trial is testing

Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma

Who this might be right for
Multiple MyelomaLymphoma
M.D. Anderson Cancer Center 168
Not applicableStudy completedNCT00510315
What this trial is testing

Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant

Who this might be right for
LeukemiaHodgkin's LymphomaNon-Hodgkin's Lymphoma+1 more
Memorial Sloan Kettering Cancer Center 11
Testing effectiveness (Phase 2)WithdrawnNCT01170052
What this trial is testing

Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Mantle Cell Lymphoma
Charite University, Berlin, Germany 20
Not applicableUnknownNCT00231712
What this trial is testing

Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell Transplant

Who this might be right for
LeukemiaMedulloblastoma
Julius-Maximilians University 50
Testing effectiveness (Phase 2)Study completedNCT00793572
What this trial is testing

Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma

Who this might be right for
Refractory Plasma Cell Myeloma
Fred Hutchinson Cancer Center 32
Early research (Phase 1)Study completedNCT01163357
What this trial is testing

Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma

Who this might be right for
Autologous Hematopoietic Stem Cell Transplant RecipientLoss of Chromosome 17pPlasma Cell Leukemia+2 more
City of Hope Medical Center 18
Early research (Phase 1)Study completedNCT00002787
What this trial is testing

Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 22
Testing effectiveness (Phase 2)Study completedNCT01919619
What this trial is testing

Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies

Who this might be right for
B-Cell Non-Hodgkin LymphomaHematopoietic and Lymphoid Cell NeoplasmLeukemia+3 more
M.D. Anderson Cancer Center 41
Testing effectiveness (Phase 2)WithdrawnNCT00728585
What this trial is testing

Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant

Who this might be right for
Gastrointestinal MucositisMalignant Neoplasm
Children's Oncology Group
Testing effectiveness (Phase 2)Study completedNCT03961919
What this trial is testing

Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesTransplant-Related Hematologic Malignancy
Ciceri Fabio 15
Testing effectiveness (Phase 2)Study completedNCT00005803
What this trial is testing

Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma

Who this might be right for
Prolymphocytic LeukemiaRecurrent Adult Hodgkin LymphomaRecurrent Childhood Hodgkin Lymphoma+11 more
Fred Hutchinson Cancer Center 76
Testing effectiveness (Phase 2)Ended earlyNCT00121186
What this trial is testing

S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 1
Early research (Phase 1)Study completedNCT00809250
What this trial is testing

Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome-Refractory Anemia With Excess Blasts
Dana-Farber Cancer Institute 33
Testing effectiveness (Phase 2)Study completedNCT00656058
What this trial is testing

Montelukast to Treat Bronchiolitis Obliterans

Who this might be right for
Bronchiolitis ObliteransChronic Graft Versus Host DiseaseLeukotriene+2 more
National Cancer Institute (NCI) 25
Not applicableStudy completedNCT02257931
What this trial is testing

Gram-negative Bacteremia in HSCT Recipients

Who this might be right for
Allogeneic or Autologous HSCT
European Society for Blood and Marrow Transplantation 591
Testing effectiveness (Phase 2)Study completedNCT00044733
What this trial is testing

Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell Transplant

Who this might be right for
Acute Myelogenous Leukemia
Wyeth is now a wholly owned subsidiary of Pfizer 38
Not applicableStudy completedNCT03467087
What this trial is testing

Safety and Feasibility of Electrical Muscle Stimulation During Stem Cell Transplantation or Intensive Chemotherapy

Who this might be right for
Electric Stimulation Therapy
University Hospital, Saarland 45
Testing effectiveness (Phase 2)Study completedNCT00144092
What this trial is testing

HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma

Who this might be right for
Low Grade Lymphoma
Alberta Health services 60
Large-scale testing (Phase 3)UnknownNCT02059720
What this trial is testing

Haplo-SCT vs ASCT With or Without Decitabine in AML CR1

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 212
Testing effectiveness (Phase 2)Study completedNCT00802113
What this trial is testing

Autologous and Allogeneic Transplant for Relapsed Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaHodgkins Disease
Columbia University 30
Next Page